The US Senate Judiciary Committee has passed six bills aimed at lowering drug prices by addressing patent abuse and market competition-limiting tactics used by pharmaceutical companies.
“These bills won’t just level the playing field for smaller companies. They’ll help make prescription drugs more affordable for the people who need them,” said the Committee’s chairman senator Chuck...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?